Back
Flowserve Corp. 10K Form
Sell
38
FLS
Flowserve Corp.
Last Price:
$52.42
Seasonality Move:
5.07%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
2024-04-29 | 10Q | FLS/Flowserve Corp. Quarterly |
2024-02-20 | 10K | FLS/Flowserve Corp. Annual |
2023-10-25 | 10Q | FLS/Flowserve Corp. Quarterly |
2023-08-01 | 10Q | FLS/Flowserve Corp. Quarterly |
2023-05-01 | 10Q | FLS/Flowserve Corp. Quarterly |
2023-03-07 | 10K | FLS/Flowserve Corp. Annual |
Receive FLS News And Ratings
See the #1 stock for the next 7 days that we like better than FLS
FLS Financial Statistics
Sales & Book Value
Annual Sales: | $4.6B |
---|---|
Cash Flow: | $137.5M |
Price / Cash Flow: | 17.37 |
Annual Sales: | $17.03 |
Price / Book: | 3.08 |
Profitability
EPS (TTM): | 2.21000 |
---|---|
Net Income (TTM): | $314.5M |
Gross Margin: | $1.5B |
Return on Equity: | 14.86% |
Return on Assets: | 5.8% |
Flowserve Corp. Earnings Forecast
Key Flowserve Corp. Financial Ratios
-
The Gross Profit Margin over the past 45 years for FLS is 32.16%.
-
The Selling, General & Administrative Expenses for FLS have been equal to 21.46% of Gross Profit Margin.
-
The Research & Development expenses have been 1.53% of Revenue.
-
The Interest Expense is 23.01% of Operating Income.
-
The Net Earning history of FLS is 6.61% of Total Revenues.
-
Per Share Earnings over the last 45 years have been positive in 23 years.
Flowserve Corp. Stock Price Chart
Industry, Sector and Symbol
Stock Exchange: | S&P500 |
---|---|
Industry: | Machinery |
Sector: | Industrials |
Current Symbol: | FLS |
CUSIP: | 34354P |
Website: | flowserve.com |
Debt
Debt-to-Equity Ratio: | 0.75 |
---|---|
Current Ratio: | 2.1 |
Quick Ratio: | 1.48 |
Price-to-Earnings
Trailing P/E Ratio: | 24.54 |
---|---|
Forward P/E Ratio: | 13.8 |
FLS Technical Analysis vs Fundamental Analysis
Sell
38
Flowserve Corp. (FLS)
is a Sell
Is Flowserve Corp. a Buy or a Sell?
-
Flowserve Corp. stock is rated a SellThe current Flowserve Corp. [FLS] share price is $52.42. The Score for FLS is 38, which is 24% below its historic median score of 50, and infers higher risk than normal.